Epidermal growth factor antagonizes vasopressin in vivo and in vitro
- 1 April 1994
- journal article
- Published by Elsevier in Kidney International
- Vol. 45 (4), 1028-1036
- https://doi.org/10.1038/ki.1994.139
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Fluid balance, electrolyte profiles and plasma parathyroid hormone concentrations in ewes treated with epidermal growth factorJournal of Endocrinology, 1992
- Epidermal growth factor alters milk composition and fluid balance of lactating ewesJournal of Endocrinology, 1992
- [3H]desGly-NH29-d(CH2)5[D-Ileu2,Ileu4]AVP: An AVP V2 receptor antagonist radioligandPeptides, 1991
- Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure.Journal of Clinical Investigation, 1989
- Growth factor regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-I, acidic and basic fibroblast growth factor, and transforming growth factor-β in serum free cultureCell Biology International Reports, 1989
- Effect of epidermal growth factor on sodium transport in the cortical collecting tubuleAmerican Journal of Physiology-Renal Physiology, 1989
- [125I]-[d(CH2)5, Sar7] AVP: A Selective Radioligand for V1Vasopressin ReceptorsJournal of Receptor Research, 1989
- Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule.Journal of Clinical Investigation, 1988
- EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin IIAmerican Journal of Physiology-Renal Physiology, 1987
- PLASMA ATRIAL NATRIURETIC PEPTIDE: CONCENTRATIONS AND CIRCULATING FORMS IN NORMAL MAN AND PATIENTS WITH CHRONIC RENAL FAILUREClinical and Experimental Pharmacology and Physiology, 1987